Literature DB >> 6681646

Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients.

R V Randall, E R Laws, C F Abboud, M J Ebersold, P C Kao, B W Scheithauer.   

Abstract

One hundred patients, 84 females and 16 males, with presumed prolactin-producing pituitary adenomas were treated with transsphenoidal microsurgery. Criteria for success of the operation were return of serum prolactin values to normal and reversal of the endocrine effects of hyperprolactinemia, eradication of the adenoma, and preservation of anterior pituitary function. Of the 84 females, 54 had a microadenoma (a noninvasive adenoma 10 mm or less in diameter), and of the 32 with preoperative values of serum prolactin of less than 100 ng/ml, 28 (88%) had a successful operative result, whereas 11 of 22 (50%) with preoperative values of 100 ng/ml or more had a successful result. Five of 10 patients (50%) with a diffuse adenoma (a noninvasive adenoma more than 10 mm in diameter) and 5 of 20 (25%) with an invasive adenoma had a successful result. Of the 16 males, 3 of 7 (43%) with diffuse adenoma and 3 of 16 (19%) with invasive adenoma had a successful result. There were no males with microadenoma. The largest success rate (88%) was among female patients with microadenoma and preoperative serum prolactin values of less than 100 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681646

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  22 in total

1.  Medical and surgical management of microprolactinoma.

Authors:  William T Couldwell; Martin H Weiss
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

2.  Meningitis after transsphenoidal pituitary adenoma removal, but without CSF-fistula.

Authors:  G Hamann; H Bonkhoff; K Schimrigk
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.

Authors:  P Cappabianca; A Alfieri; A Colao; D Ferone; G Lombardi; E de Divitiis
Journal:  Skull Base Surg       Date:  1999

4.  Study of hypotonic polyuria after trans-sphenoidal pituitary adenomectomy.

Authors:  P Hans; A Stevenaert; A Albert
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

5.  Treatment of presumed prolactinoma by transsphenoidal operation: early and late results.

Authors:  J A Thomson; G M Teasdale; D Gordon; D C McCruden; D L Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-30

6.  Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.

Authors:  F Grisoli; T Brue; N Graziani; R Costa; J Trouillas; D Begou; P Jaquet
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 7.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

8.  Treatment of prolactinomas with megavoltage radiotherapy.

Authors:  A Grossman; B L Cohen; M Charlesworth; P N Plowman; L H Rees; J A Wass; A E Jones; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

9.  Present status of neurosurgery in the treatment of prolactinomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

10.  Long-acting bromocriptine for the acute treatment of large macroprolactinomas.

Authors:  A Zarate; C Moran; R Miranda; M Loyo; M Medina; M E Fonseca
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.